Literature DB >> 4336860

Inhibition of cytomegalovirus by rifampin.

C C Halsted, A B Minnefor, P S Lietman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4336860     DOI： 10.1093/infdis/125.5.552

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  4 in total

1.  Ultrastructural study on the sequence of human cytomegalovirus infection in human diploid cells.

Authors:  Y Iwasaki; T Furukawa; S Plotkin; H Koprowski
Journal:  Arch Gesamte Virusforsch       Date:  1973

Review 2.  Infectious diseases: annual review of significant publications.

Authors:  H A Reimann
Journal:  Postgrad Med J       Date:  1973-05       Impact factor: 2.401

3.  Plaque inhibition assay for drug susceptibility testing of influenza viruses.

Authors:  F G Hayden; K M Cote; R G Douglas
Journal:  Antimicrob Agents Chemother       Date:  1980-05       Impact factor: 5.191

Review 4.  Rifampicin for COVID-19.

Authors:  George D Panayiotakopoulos; Dimitrios T Papadimitriou
Journal:  World J Virol       Date:  2022-03-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.